E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/8/2006 in the Prospect News Biotech Daily.

Acadia settles civil suit; litigation fees total $9.1 million

By Elaine Rigoli

Tampa, Fla., Sept. 8 - Acadia Pharmaceuticals, Inc. said it reached a settlement in a civil action filed by a former employee.

The company recorded an accrued loss from litigation totaling $9.1 million as of June 30, which included the amount awarded for damages and plaintiff's fees and costs, plus accrued interest on those awards.

To settle the litigation inclusive of all fees and costs, pursuant to the agreement, the San Diego biopharmaceutical company said it will make aggregate payments of $5.15 million, of which approximately $2.4 million will be covered by Acadia's employment practices liability insurance.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.